{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T01:20:05Z","timestamp":1789435205704,"version":"build-2803163510"},"reference-count":162,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anti-infective Therapy"],"published-print":{"date-parts":[[2019,6,3]]},"DOI":"10.1080\/14787210.2019.1610392","type":"journal-article","created":{"date-parts":[[2019,4,20]],"date-time":"2019-04-20T12:13:16Z","timestamp":1555762396000},"page":"387-401","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":24,"title":["Developments on antibiotics for multidrug resistant bacterial Gram-negative infections"],"prefix":"10.1080","volume":"17","author":[{"given":"Georgios L.","family":"Voulgaris","sequence":"first","affiliation":[{"name":"Alfa Institute of Biomedical Sciences, Athens, Greece"},{"name":"Laboratory of Pharmacokinetics and Toxicology, Department of Pharmacy, 401 General Military Hospital, Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria L.","family":"Voulgari","sequence":"additional","affiliation":[{"name":"Alfa Institute of Biomedical Sciences, Athens, Greece"},{"name":"Department of Internal Medicine, Hospital Neuwittelsbach of the Sisters of Mercy, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E.","family":"Falagas","sequence":"additional","affiliation":[{"name":"Alfa Institute of Biomedical Sciences, Athens, Greece"},{"name":"Department of Medicine, Henry Dunant Hospital Center, Athens, Greece"},{"name":"Department of Medicine, Tufts University School of Medicine, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,5,27]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.10.028"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.3201\/eid2007.121004"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00068-15"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000109"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis857"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30753-3"},{"issue":"108","key":"CIT0007","first-page":"32464","volume":"79","author":"FDA","year":"2014","journal-title":"Fed Regist"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.3109\/00498254.2015.1042946"},{"key":"CIT0009","volume-title":"A phase I, 3-part placebo-controlled randomised trial to evaluate the safety, tolerability and pharmacokinetics of aztreonam-avibactam in healthy subjects","author":"Timi Edeki DZ","year":"2016"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1205073109"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02247-12"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/52.6_Suppl_2.S15"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03057-14"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh358"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.09.012"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M113.485979"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00897-16"},{"key":"CIT0018","volume-title":"AVYCAZ (ceftazidime\/avibactam) Full Prescribing Information","author":"FDA","year":"2016"},{"key":"CIT0019","volume-title":"Summary of product characteristics ZAVICEFTA (ceftazidime\/avibactam)","author":"EMA"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00163-15"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01045-17"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02286-15"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00548-15"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky267"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01587-18"},{"key":"CIT0026","volume-title":"Emergence of resistance to ceftazidime-avibactam in carbapenem-resistant Enterobacteriaceae Stockholm","author":"ECDC","year":"2018"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02446-17"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01989-12"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw231"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00206-15"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00472-17"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01856-17"},{"key":"CIT0033","author":"Castanheira M","year":"2013","journal-title":"Escmid Abstr"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv132"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198909001-00008"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2001.11927741"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199410040-00006"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01224-17"},{"key":"CIT0039","volume-title":"VABOMRE (meropenem\/vaborbactam) Full Prescribing Information","author":"FDA","year":"2018"},{"key":"CIT0040","volume-title":"Summary of Product Characteristics VABOMERE (meropenem\/vaborbactam)","author":"EMA"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767070-00006"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00711-16"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00127"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01443-17"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00843-15"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01694-17"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00567-17"},{"key":"CIT0048","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01904-17"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01659-18"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00568-16"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198733030-00001"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.12.101"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00830-15"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2018.07.012"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02209-16"},{"issue":"10","key":"CIT0056","first-page":"2286","volume":"68","author":"Livermore DM","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00533-18"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02323-17"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx139"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00633-16"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00280-18"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00834-09"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0168-2"},{"key":"CIT0064","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq248"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01737-10"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01752-10"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02513-12"},{"key":"CIT0068","volume-title":"Summary of product characteristics ZERBAXA (ceftolozane\/tazobactam)","author":"EMA"},{"key":"CIT0069","volume-title":"ZERBAXA (ceftolozane\/tazobactam) Full Prescribing Information","author":"FDA","year":"2014"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks246"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.566"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.04.004"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku184"},{"issue":"2","key":"CIT0074","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijantimicag.2017.09.016","volume":"51","author":"Pfaller MA","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"CIT0075","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2017.06.008"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02969-15"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx009"},{"key":"CIT0078","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00875-17"},{"key":"CIT0079","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01288-13"},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0545-8"},{"key":"CIT0081","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.06187-11"},{"key":"CIT0082","doi-asserted-by":"publisher","DOI":"10.1038\/s41426-018-0141-y"},{"key":"CIT0083","volume-title":"XERAVA (eravacycline) full prescribing information","author":"FDA","year":"2018"},{"key":"CIT0084","volume-title":"Xerava: product information","author":"EMA","year":"2018"},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2017.12.013"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04809-14"},{"key":"CIT0087","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00436-16"},{"key":"CIT0088","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.06.022"},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02206-17"},{"key":"CIT0090","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00250-17"},{"key":"CIT0091","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01174-18"},{"key":"CIT0092","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01810-18"},{"key":"CIT0093","volume-title":"Plazomicin: a next-generation aminoglycoside","author":"Shaeer KM"},{"key":"CIT0094","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2010.09.004"},{"key":"CIT0095","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00572-10"},{"key":"CIT0096","volume-title":"Investigating the Post-Antibiotic Effect (PAE) of plazomicin against multidrug-resistant enterobacteriaceae","author":"Hall D","year":"2017"},{"key":"CIT0097","doi-asserted-by":"publisher","DOI":"10.1586\/eri.12.25"},{"key":"CIT0098","volume-title":"Prescribing information for ZEMDRI","author":"FDA","year":"2018"},{"key":"CIT0099","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02068-18"},{"key":"CIT0100","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00313-18"},{"key":"CIT0101","volume-title":"Xerava: EPAR - product \u0399nformation","author":"European Medicines Agency, E.M.","year":"2018"},{"key":"CIT0102","volume-title":"In vitro activity of plazomicin, a next-generation aminoglycoside, against carbapenemase-producing Klebsiella pneumoniae","author":"Jacobs MR","year":"2018"},{"key":"CIT0103","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01989-17"},{"key":"CIT0104","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2017.49.1.31"},{"key":"CIT0105","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2050"},{"key":"CIT0106","volume-title":"BAXDELA full prescribing information","author":"FDA","year":"2017"},{"key":"CIT0107","doi-asserted-by":"publisher","DOI":"10.1021\/jm0205090"},{"key":"CIT0108","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.01.094"},{"key":"CIT0109","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03482-14"},{"key":"CIT0110","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01201-10"},{"key":"CIT0111","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.10.3260-3269.2003"},{"key":"CIT0112","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2015.11.019"},{"key":"CIT0113","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1041"},{"key":"CIT0114","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.817"},{"key":"CIT0115","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.7.2771-2777.2004"},{"key":"CIT0116","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00772-17"},{"key":"CIT0117","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02609-16"},{"key":"CIT0118","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00941-16"},{"key":"CIT0119","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx329"},{"key":"CIT0120","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy165"},{"key":"CIT0121","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv411"},{"key":"CIT0122","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2014.10.009"},{"key":"CIT0123","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy220"},{"key":"CIT0124","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.04813-14"},{"key":"CIT0125","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01695-15"},{"key":"CIT0126","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-009-9219-2"},{"key":"CIT0127","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv402"},{"key":"CIT0128","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01022-17"},{"key":"CIT0129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2017.10.008"},{"key":"CIT0130","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00093-17"},{"key":"CIT0131","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-017-3063-z"},{"key":"CIT0132","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00700-17"},{"key":"CIT0133","author":"Hsueh SC","year":"201","journal-title":"J Antimicrob Chemother"},{"key":"CIT0134","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03098-15"},{"key":"CIT0135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2018.11.005"},{"key":"CIT0136","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01801-18"},{"key":"CIT0137","doi-asserted-by":"publisher","DOI":"10.1159\/000487441"},{"key":"CIT0138","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx049"},{"key":"CIT0139","author":"Kazmierczak KM","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"CIT0140","author":"Karlowsky JA","journal-title":"Int J Antimicrob Agents"},{"key":"CIT0141","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00576-17"},{"key":"CIT0142","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01381-16"},{"key":"CIT0143","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01391-17"},{"key":"CIT0144","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02163-17"},{"key":"CIT0145","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq375"},{"key":"CIT0146","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00833-10"},{"key":"CIT0147","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01637-09"},{"key":"CIT0148","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02446-16"},{"key":"CIT0149","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1983.tb00129.x"},{"key":"CIT0150","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.07.006"},{"key":"CIT0151","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr393"},{"key":"CIT0152","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00832-10"},{"key":"CIT0153","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01122-17"},{"key":"CIT0154","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02325-17"},{"key":"CIT0155","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02317-17"},{"key":"CIT0156","author":"Dillon C","journal-title":"Expert Rev Anti Infect Ther"},{"key":"CIT0157","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2166"},{"key":"CIT0158","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01497-17"},{"key":"CIT0159","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a027110"},{"key":"CIT0160","volume":"2018","author":"Mittal J","year":"2018","journal-title":"BMJ Case Rep"},{"key":"CIT0161","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02463-18"},{"key":"CIT0162","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky136"}],"container-title":["Expert Review of Anti-infective Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14787210.2019.1610392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T11:38:41Z","timestamp":1559561921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14787210.2019.1610392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,27]]},"references-count":162,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,5,15]]},"published-print":{"date-parts":[[2019,6,3]]}},"alternative-id":["10.1080\/14787210.2019.1610392"],"URL":"https:\/\/doi.org\/10.1080\/14787210.2019.1610392","relation":{},"ISSN":["1478-7210","1744-8336"],"issn-type":[{"value":"1478-7210","type":"print"},{"value":"1744-8336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,27]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierz20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-01-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-04-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}